BioLattice Ophthalmics, Inc, research brief
CIK 2125596
Generated Nov. 18, 2026, 9:29 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: Philadelphia Pennsylvania. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- Oct. 28, 2026 · D/A · 0002125596-26-000003 · Source evidence
Reported offering amount: 3310000 USD. Reported amount sold: 1825000 USD.
- March 30, 2026 · D · 0002125596-26-000001 · Source evidence
Reported offering amount: 2500000 USD. Reported amount sold: 575000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “BioLattice Ophthalmics, Inc, research brief,” CIK 2125596, retrieved Nov. 18, 2026, 9:29 a.m.. Cite the specific accessions used. No amounts have been summed.